突触前多巴胺能成像可表征突触核蛋白病所致快速眼动睡眠行为障碍患者
该多中心研究纳入173例经多导睡眠图确诊的快速眼动睡眠行为障碍(RBD)患者并最终转化为突触核蛋白病,另纳入232例未转化RBD患者和160例对照,采用机器学习分析临床与突触前多巴胺能成像数据。结果显示临床数据单独预测转化能力差,突触前多巴胺能成像显著改善预测,区分突触核蛋白病所致RBD与未转化RBD的灵敏度77%、特异度85%,区分帕金森病转化者与痴呆伴路易体转化者的灵敏度85%、特异度86%。
要点
- 临床数据单独预测RBD向突触核蛋白病转化能力差。
- 突触前多巴胺能成像显著改善转化预测,联合临床数据时区分突触核蛋白病所致RBD与未转化RBD的灵敏度77%、特异度85%。
- 突触前多巴胺能成像区分帕金森病转化者与痴呆伴路易体转化者的灵敏度85%、特异度86%。
核心结论
- 临床数据单独预测突触核蛋白病所致RBD患者的转化能力差,而突触前多巴胺能成像能较好地预测即将发生的转化诊断,该发现可能用于设计未来的疾病修饰试验。
研究设计与样本
- 国际RBD研究组的多中心研究,纳入173例经多导睡眠图确诊的RBD患者(平均年龄70.5±6.3岁,男性70.5%)并最终转化为显性α-突触核蛋白病,另纳入232例未转化RBD患者(67.6±7.1岁,男性78.4%)和160例对照(68.2±7.2岁,男性53.1%)。
- 所有受试者接受基线突触前多巴胺能成像和临床评估,包括运动、认知、嗅觉和便秘评估。
- 采用机器学习分析影像和临床特征以确定转化预测因子。
主要发现
- 机器学习分析显示临床数据单独预测转化能力差。
- 突触前多巴胺能成像显著改善预测,尤其与临床数据联合时,区分突触核蛋白病所致RBD与未转化RBD患者的灵敏度77%、特异度85%,区分帕金森病转化者与痴呆伴路易体转化者的灵敏度85%、特异度86%。
- 突触前多巴胺能成像定量显示,最受累半球壳核的经验性z分数截断值-1.0可表征突触核蛋白病所致RBD患者,而最受累半球壳核/尾状核比值的截断值-1.0可表征帕金森病转化者。
关键数值与推荐
- 突触前多巴胺能成像联合临床数据区分突触核蛋白病所致RBD与未转化RBD:灵敏度77%,特异度85%。
- 突触前多巴胺能成像区分帕金森病转化者与痴呆伴路易体转化者:灵敏度85%,特异度86%。
- 最受累半球壳核z分数截断值-1.0表征突触核蛋白病所致RBD患者。
- 最受累半球壳核/尾状核比值截断值-1.0表征帕金森病转化者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To apply a machine learning analysis to clinical and presynaptic dopaminergic imaging data of patients with rapid eye movement (REM) sleep behavior disorder (RBD) to predict the development of Parkinson disease (PD) and dementia with Lewy bodies (DLB). METHODS: In this multicenter study of the International RBD study group, 173 patients (mean age 70.5 ± 6.3 years, 70.5% males) with polysomnography-confirmed RBD who eventually phenoconverted to overt alpha-synucleinopathy (RBD due to synucleinopathy) were enrolled, and underwent baseline presynaptic dopaminergic imaging and clinical assessment, including motor, cognitive, olfaction, and constipation evaluation. For comparison, 232 RBD non-phenoconvertor patients (67.6 ± 7.1 years, 78.4% males) and 160 controls (68.2 ± 7.2 years, 53.1% males) were enrolled. Imaging and clinical features were analyzed by machine learning to determine predictors of phenoconversion. RESULTS: Machine learning analysis showed that clinical data alone poorly predicted phenoconversion. Presynaptic dopaminergic imaging significantly improved the prediction, especially in combination with clinical data, with 77% sensitivity and 85% specificity in differentiating RBD due to synucleinopathy from non phenoconverted RBD patients, and 85% sensitivity and 86% specificity in discriminating PD-converters from DLB-converters. Quantification of presynaptic dopaminergic imaging showed that an empirical z-score cutoff of -1.0 at the most affected hemisphere putamen characterized RBD due to synucleinopathy patients, while a cutoff of -1.0 at the most affected hemisphere putamen/caudate ratio characterized PD-converters. INTERPRETATION: Clinical data alone poorly predicted phenoconversion in RBD due to synucleinopathy patients. Conversely, presynaptic dopaminergic imaging allows a good prediction of forthcoming phenoconversion diagnosis. This finding may be used in designing future disease-modifying trials. ANN NEUROL 2024;95:1178-1192.
引用
- Arnaldi D, Mattioli P, Raffa S, et al. Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy. Ann Neurol. 2024. PMID: 38466158. doi:10.1002/ana.26902
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。